Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 7:38 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2281–2304 of 2,478 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Tissue Control Group Clear all

Conditions: Advanced Solid Tumors
Interventions: Talazoparib; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 11
States / cities: Alhambra, California • Bakersfield, California • Fullerton, California + 7 more

Conditions: Venous Thromboembolism, Pulmonary Embolism
Interventions: dalteparin injection; Drug
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 218 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 6
States / cities: Sacramento, California • Buffalo, New York • Rochester, New York + 2 more

Conditions: Covid19, Stage 1 Acute Kidney Injury
Interventions: MIB-626, Placebo, Home Treatment; Drug · Other
Lead sponsor: Metro International Biotech, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Sinusitis
Interventions: Not listed
Lead sponsor: Ohio State University; Other
Eligibility: 5 Years to 90 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Multiple Sclerosis, Fatigue
Interventions: Self-Hypnosis (HYP), Mindfulness Meditation (MM); Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 333 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Knee Osteoarthritis, Knee Arthritis, Knee Pain Chronic, Knee Deformity, Knee Pain Swelling, Muscle Weakness, Muscle Weakness Condition, Power
Interventions: Manual Physical Therapy; Procedure
Lead sponsor: Jennifer Moreno Clinic; Other
Eligibility: 45 Years to 74 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Fort Sam Houston, Texas

Conditions: Endocrine Dysfunction, Trauma, Brain Injury
Interventions: Androgel (Testosterone Gel), Placebo gel; Drug · Other
Lead sponsor: Craig Hospital; Other
Eligibility: 16 Years to 65 Years · Male only
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Englewood, Colorado

Conditions: Traumatic Brain Injury
Interventions: Sildenafil Citrate 50Mg Tab, functional Near-infrared Spectroscopy (fNIRS), Carbon Dioxide (CO2) 5%, Neuropsychological Assessments, Gadolinium contrast infusion, Blood sample collection for research purposes, Structural brain Magnetic Resonance Imaging (MRI; Drug · Device · Other + 1 more
Lead sponsor: Uniformed Services University of the Health Sciences; Federal
Eligibility: 18 Years to 55 Years
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Carotid Artery Diseases, Peripheral Arterial Disease
Interventions: Pegulicianine, Placebo; Drug · Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Adhesive Capsulitis, Post-operative Pain
Interventions: Interscalene catheter with Ropivicaine or normal saline; Procedure
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: San Diego, California

Conditions: Osteoarthritis, Knee
Interventions: Periosteal stimulation, Control-Periosteal Stimulation; Other
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 50 Years to 89 Years
Enrollment: 190 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Plasmodium Falciparum Infection
Interventions: Chloroquine, PfSPZ (NF54) Challenge, Placebo; Drug · Biological · Other
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 45 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Acute Compartment Syndrome, Fracture, Bone, Tibial Fractures
Interventions: Tissue Ultrafiltration Catheters; Device
Lead sponsor: Major Extremity Trauma Research Consortium; Other
Eligibility: 18 Years to 60 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 4
States / cities: Baltimore, Maryland • Minneapolis, Minnesota • Charlotte, North Carolina + 1 more

Conditions: Pain
Interventions: Saline, Lidocaine / propofol admixture, lidocaine pretreatment; Drug
Lead sponsor: Benaroya Research Institute; Other
Eligibility: 18 Years to 80 Years
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Pain
Interventions: IV acetaminophen, placebo; Drug
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 75 Years · Female only
Enrollment: 183 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Fuchs' Endothelial Dystrophy, Corneal Edema
Interventions: Endothelial keratoplasty, PRGF; Procedure · Biological
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Miami, Florida • Indianapolis, Indiana

Conditions: Polycystic Ovary Syndrome, Infertility, Female
Interventions: May Health System; Device
Lead sponsor: May Health; Industry
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 93 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 19
States / cities: Encino, California • San Francisco, California • Tampa, Florida + 16 more

Conditions: Hepatic Impairment
Interventions: Tucatinib; Drug
Lead sponsor: Seagen Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 4
States / cities: Tustin, California • Orlando, Florida • Knoxville, Tennessee + 1 more

Conditions: Prostate Cancer, Prostate Cancer (Diagnosis), High-risk Prostate Cancer, Localized Prostate Carcinoma, Very High Risk Prostate Carcinoma
Interventions: 177 Lutetium Prostate-Specific Membrane Antigen 617, Actinium-225 Prostate-Specific Membrane Antigen 617, Non-investigational, Prostatectomy, Prostate Tissue Collection, Single-photon emission computed tomography (SPECT)/Computerized tomography (CT), Blood Sample Collection; Drug · Procedure
Lead sponsor: Thomas Hope; Other
Eligibility: 18 Years and older · Male only
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Acute Pain, Pain, Postoperative, Colorectal Surgery
Interventions: Placebo, Ketamine, Acetaminophen, Opioid, Alvimopan; Drug
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Function of Renal Transplant
Interventions: Aminophylline, Theophylline drug levels, Placebo; Drug · Other
Lead sponsor: Stanford University; Other
Eligibility: 1 Year to 21 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Stanford, California

Conditions: Healthy Volunteers in Fed and Fasted State
Interventions: Dexmethylphenidate; Drug
Lead sponsor: Cingulate Therapeutics; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: Schizophrenia, Psychotic Disorders
Interventions: Tocilizumab, Normal saline; Drug
Lead sponsor: Brian Miller; Other
Eligibility: 18 Years to 55 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Meibomian Gland Dysfunction, Dry Eye Syndromes, Dry Eye
Interventions: Tixel C, LipiFlow; Device
Lead sponsor: Novoxel Ltd.; Industry
Eligibility: 22 Years and older
Enrollment: 109 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 5
States / cities: La Jolla, California • Newport Beach, California • Kansas City, Missouri + 2 more

Search by objective public record fields.

An Open-Label Pharmacokinetics and Safety Study of Talazoparib (MDV3800)

A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients

Phase 2a MIB-626 vs. Placebo COVID-19

Clinical Study to Improve Diagnosis and Treatment of Sinusitis

Use of Audio Recordings of Self-Hypnosis and Meditation for Fatigue Management in Multiple Sclerosis

Rate of Torque Development and Voluntary Quadriceps Activation in Patients With Knee Osteoarthritis: A Quantitative Analysis Before and After a Single Session of Manual Physical Therapy

Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy

Cerebrovascular Reactivity Assessed With fNIRS as a Biomarker of TCVI After Acute Traumatic Brain Injury in Military

Study to Image Inflammatory Activity of a Fluorescence Imaging Agent in Excised Human Artery Plaques

Shoulder Adhesive Capsulitis and Ambulatory Continuous Interscalene Nerve Blocks

Periosteal Stimulation for Knee Osteoarthritis

PfSPZ Challenge in Healthy Malaria-Naïve Adults in the United States

Evaluation of the Diagnostic and Therapeutic Value of Tissue Ultrafiltration in Patients at Risk of Acute Compartment Syndrome (ACS)

Preventing Propofol-associated Injection Pain

IV Acetaminophen for Postoperative Pain Analgesia After Laparoscopic Hysterectomy

Plasma Rich in Growth Factors in Corneal Endothelial Transplantation

The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System

A Safety Study of Tucatinib in Healthy and Hepatically-Impaired Subjects

Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617

Ketamine in Colorectal Surgery

Perioperative Aminophylline to Improve Early Kidney Function After a Kidney Transplant

In-clinic Crossover Study in Subjects With Two Treatments (Fed vs Fasted)

Tocilizumab in Schizophrenia

to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction